Parag  Mallick net worth and biography

Parag Mallick Biography and Net Worth

Dr. Parag Mallick is an Associate Professor at Stanford University, and an interdisciplinary scientist, who has developed multi-scale approaches to accelerate the discovery of diagnostic and prognostic protein biomarkers. Parag trained with pioneering researcher Ruedi Aebersold in clinical proteomics and systems biology at the Institute for Systems Biology. Parag holds a BS degree in Computer Science from Washington University in St. Louis, and a PhD in Chemistry & Biochemistry from UCLA. He has over 100 publications and holds patents in the fields of artificial intelligence, proteomics technology, biomarker development, and nanotechnology.

What is Parag Mallick's net worth?

The estimated net worth of Parag Mallick is at least $76.85 million as of May 12th, 2025. Mallick owns 20,493,392 shares of Nautilus Biotechnology stock worth more than $76,850,220 as of March 24th. This net worth approximation does not reflect any other assets that Mallick may own. Additionally, Mallick receives a salary of $562,800.00 as Insider at Nautilus Biotechnology. Learn More about Parag Mallick's net worth.

How old is Parag Mallick?

Mallick is currently 46 years old. There are 5 older executives and 2 younger executives at Nautilus Biotechnology. The oldest executive at Nautilus Biotechnology is Ms. Gwen E. Weld, Chief People Officer, who is 66 years old. Learn More on Parag Mallick's age.

What is Parag Mallick's salary?

As the Insider of Nautilus Biotechnology, Inc., Mallick earns $562,800.00 per year. The highest earning executive at Nautilus Biotechnology is Mr. Sujal M. Patel, Co-Founder, CEO, President, Secretary & Director, who commands a salary of $827,240.00 per year. Learn More on Parag Mallick's salary.

How do I contact Parag Mallick?

The corporate mailing address for Mallick and other Nautilus Biotechnology executives is 51 ASTOR PLACE 10TH FLOOR, NEW YORK NY, 10003. Nautilus Biotechnology can also be reached via phone at 206-333-2001 and via email at [email protected]. Learn More on Parag Mallick's contact information.

Has Parag Mallick been buying or selling shares of Nautilus Biotechnology?

Parag Mallick has not been actively trading shares of Nautilus Biotechnology during the last quarter. Most recently, on Monday, May 12th, Parag Mallick bought 1,500 shares of Nautilus Biotechnology stock. The stock was acquired at an average cost of $0.73 per share, with a total value of $1,095.00. Following the completion of the transaction, the insider now directly owns 20,493,392 shares of the company's stock, valued at $14,960,176.16. Learn More on Parag Mallick's trading history.

Who are Nautilus Biotechnology's active insiders?

Nautilus Biotechnology's insider roster includes Mary Godwin (VP), Parag Mallick (Insider), Matthew Mcilwain (Director), Anna Mowry (CFO), Matthew Murphy (General Counsel), Sujal Patel (CEO), Matthew Posard (Director), and Kentaro Suzuki (CMO). Learn More on Nautilus Biotechnology's active insiders.

Are insiders buying or selling shares of Nautilus Biotechnology?

In the last year, Nautilus Biotechnology insiders bought shares 8 times. They purchased a total of 277,500 shares worth more than $240,250.00. The most recent insider tranaction occured on March, 4th when CEO Sujal M Patel bought 25,000 shares worth more than $65,250.00. Insiders at Nautilus Biotechnology own 41.1% of the company. Learn More about insider trades at Nautilus Biotechnology.

Information on this page was last updated on 3/4/2026.

Parag Mallick Insider Trading History at Nautilus Biotechnology

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/12/2025Buy1,500$0.73$1,095.0020,493,392View SEC Filing Icon  
5/8/2025Buy12,000$0.73$8,760.0020,491,892View SEC Filing Icon  
See Full Table

Parag Mallick Buying and Selling Activity at Nautilus Biotechnology

This chart shows Parag Mallick's buying and selling at Nautilus Biotechnology by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Nautilus Biotechnology Company Overview

Nautilus Biotechnology logo
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.
Read More

Today's Range

Now: $3.95
Low: $3.50
High: $3.98

50 Day Range

MA: $2.35
Low: $1.83
High: $3.62

2 Week Range

Now: $3.95
Low: $0.62
High: $3.98

Volume

1,131,571 shs

Average Volume

249,946 shs

Market Capitalization

$499.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.44